Multiple sclerosis (MS) represents a multifaceted neuroinflammatory disease for which regular exercise is now recommended by many healthcare institutions. Although preclinical studies indicate robust immunomodulatory effects of exercise, evidence from human studies is lacking. In this randomized controlled trial, persons with MS (pwMS) were assigned to three months of high-intensity interval training or a passive control condition, with outcomes assessed at baseline, after intervention, and a fourweek follow-up.
Exercise reshapes cellular immunity toward anti-inflammation and diminishes CCR4 levels on LFA-1αhighCD4+ T cells in multiple sclerosis
calendar_today
November 6, 2026
person
Proschinger, S., Wences Chirino, T., Hoenen, L., Trebing, S., Joisten, N., Walzik, D., Daube, N., Ellrichmann-Wilms, G., Ahmadi, S., Schneider, M., Zadora, P., Frey, D. L., Meuth, S. G., Pawlitzki, M., Masanneck, L., Kuhle, J., Ruck, T., Rehmann, R., Henneberg, A. L., Opitz, C. A., Zimmer, P.
domain
medrxiv